INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

PFS Partners, LLC's Holding History (CIK: 0002002654)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 300 Value ($000) $40 Avg Close — Range —
Q4 2024
Shares 300 Value ($000) $25 Avg Close — Range —
Q3 2024
Shares 300 Value ($000) $22 Avg Close — Range —
Q2 2024
Shares 300 Value ($000) $21 Avg Close — Range —
Q1 2024
Shares 300 Value ($000) $21 Avg Close — Range —
Q4 2023
Shares 512 Value ($000) $37 Avg Close — Range —
Q3 2023
Shares 512 Value ($000) $27 Avg Close — Range —
Q2 2023
Shares 512 Value ($000) $32 Avg Close — Range —
Q1 2023
Shares 512 Value ($000) $28 Avg Close — Range —
Q4 2022
Shares 512 Value ($000) $27 Avg Close — Range —
Q3 2022
Shares 512 Value ($000) $24 Avg Close — Range —
Q2 2022
Shares 512 Value ($000) $29 Avg Close — Range —
Q1 2022
Shares 512 Value ($000) $31 Avg Close — Range —
Q4 2021
Shares 512 Value ($000) $27 Avg Close — Range —